IL6 and breast carcinoma: Moreover, obese bASCs have an increased secretion of IL6, which has been shown to trigger cancer cell proliferation by activating the JAK/STAT3, ERK1/2 and STAT3/NFĸB pathways in multiple cancer entities including breast cancer [81].